Doxorubicin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Doxorubicin and local guidelines before prescribing.

Anthracycline cytotoxic

Mechanism

Anthracycline intercalating DNA and inhibiting topoisomerase II.

Uses

Breast cancer, lymphoma, sarcoma, leukaemia.

Dosing

Side effects

Cardiomyopathy (cumulative dose), myelosuppression, alopecia, extravasation necrosis, red urine.

Interactions

Trastuzumab increases cardiotoxicity.

Contraindications and cautions

Cardiomyopathy, severe liver impairment

Monitoring

Echocardiogram, FBC, LFT

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in hepatic impairment

Overdose and reversal

Dexrazoxane for extravasation or cardioprotection

Special advice

Record cumulative dose; baseline echocardiogram; central access.

More from the textbook: uses, cautions and other points
Where it is discussed in the book